Hypoglycemic effects of aqueous extract of juglans regia in type 2 diabetic patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138803061957N1

Enrollment

Registered

2011-05-04

Start date

2011-03-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II diabetes mellitus. Endocrine and Metabolid Diseases

Interventions

Intervention 1: controle: toast powder capsule,TDS for 3 months. Intervention 2: Intervention group: capsules containing 250 mg powder of aquous extract of juglans regia,three times a day for 3 months

Placebo

Treatment - Drugs

controle: toast powder capsule,TDS for 3 months

Intervention group: capsules containing 250 mg powder of aquous extract of juglans regia,three times a day for 3 months.

Eligibility

Sex/Gender

All

Age

35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Type 2 diabetic patients receiving oral anti-diabetic medications with FBS 140-250 Exclusion criteria: insulin therapy, liver or kidney diseases, pregnancy, breast feeding.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fasting Blood Sugar. Timepoint: Before and After intervention. Method of measurement: Biochemistry Lab test.	—

Secondary

Measure	Time frame
2 Hr Post Prandial Glucose. Timepoint: Before and after intervention. Method of measurement: Biochemistry lab test.;HbA1c. Timepoint: Before and after intervention. Method of measurement: Blood chromatography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFataneh Hashem Dabaghian

Research Institute for Islamic and Complementary Medicine

fatanehdabaghian@yahoo.com+98 21 3311 1619

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026